- World Pharma News Home » User » normangreen » Voted
(a free service delivered by FeedBurner)
normangreen / Voted
GlaxoSmithKline (GSK) has signed an exclusive Cooperation Agreement with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (NIBT) as a preliminary step in forming a Joint Venture (JV) between the tw
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
When Wyeth named Michael Kamarck as its new head of manufacturing this week, we asked, “Who is that guy?”
Wyeth indulged us. And we found out Kamarck, 57, was trained as a biochemist read more »
Discuss Add this link to... Bury
Wyeth indulged us. And we found out Kamarck, 57, was trained as a biochemist read more »
Discuss Add this link to... Bury
AstraZeneca has announced the divestment to GlaxoSmithKline of a portfolio of over-the-counter (OTC) products predominantly sold in Sweden. The decision reinforces AstraZeneca's strategy to focus on
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
As you all know by now, American pharmaceutical companies have been intermittently laying off thousands of employees for the past two years or so. Many of the employees who have lost their jobs are R
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The European Medicines Agency (EMEA) has recommended the suspension of the marketing authorisation of Ionsys (fentanyl hydrochloride), from Janssen-Cilag International NV, because of a defect with th
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
The European Medicines Agency (EMEA) has been formally notified by Pfizer Limited of its decision to withdraw its application for a change to the marketing authorisation for the medicine Viagra (sild
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
On 19 November 2008, AstraZeneca was granted a Temporary Restraining Order (TRO) by the United States District Court for the District of New Jersey, halting sales of Teva's budesonide inhalation sus
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
Dr. Samir Hanash, Program Head at the Fred Hutchinson Cancer Research Center in Seattle, WA will give the keynote address on the discovery and development of biomarkers at the 2nd annual Oncology Bio
read more »
Discuss Add this link to... Bury
Discuss Add this link to... Bury
GTCbio just announced its 2nd Annual Oncology Biomarkers Conference taking place on January 19-20, 2009 in Miami, Florida.
The conference will take attendees through “The Life Cycle of a Cancer Biom read more »
Discuss Add this link to... Bury
The conference will take attendees through “The Life Cycle of a Cancer Biom read more »
Discuss Add this link to... Bury
Posted by
worldpharmanews
480 days ago
(http://www.worldpharmanews.com)
Category: Research & Development |
Discuss Add this link to... Bury
« previous1 next »
